With biopharma industry tuned in, Supreme Court hears arguments around medication abortion
Fierce Pharma
MARCH 26, 2024
In the wake of last year’s court decision to limit the FDA’s approval for the medication abortion pill mifepristone, many drugmakers, trade groups and even the U.S. |
Let's personalize your content